THE JUVENILE ARTHRITIS QUALITY-OF-LIFE QUESTIONNAIRE DEVELOPMENT OF ANEW RESPONSIVE INDEX FOR JUVENILE RHEUMATOID-ARTHRITIS AND JUVENILE SPONDYLOARTHRITIDES
Cm. Duffy et al., THE JUVENILE ARTHRITIS QUALITY-OF-LIFE QUESTIONNAIRE DEVELOPMENT OF ANEW RESPONSIVE INDEX FOR JUVENILE RHEUMATOID-ARTHRITIS AND JUVENILE SPONDYLOARTHRITIDES, Journal of rheumatology, 24(4), 1997, pp. 738-746
Objective, To develop a disease specific measure of quality of life fo
r application in children with juvenile rheumatoid arthritis and juven
ile spondyloarthritides - the Juvenile Arthritis Quality of Life Quest
ionnaire (JAQQ). Methods. Patients and their parents were interviewed
by a trained interviewer using a questionnaire focusing on physical fu
nction, psychosocial function, and general symptoms to determine the m
ost appropriate items to include in the JAQQ. Respondents volunteered
items and scored them for frequency of occurrence and importance. Item
s so generated were scored by a panel of experts for potential respons
iveness and categorized into dimensions. Item number was reduced using
this scoring system. The product was then pretested to confirm its co
nstruct validity and responsiveness. Thereafter, it was distributed to
clinical experts to establish face and content validity. Results, 91
patients, mean age 10.35 years (range 1.25-18.0), mean disease duratio
n 3.99 years, and their parents were included in the interview process
. 220 items generated were ultimately reduced to 85. Pretesting this v
ersion of the instrument in a further 30 patients showed it to have co
nstruct validity and responsiveness and led to a further reduction in
items to 74, distributed in 4 dimensions: gross motor function (17 ite
ms), fine motor function (16 items), psychosocial function (22 items),
and general symptoms (19 items). Face and content validity were estab
lished in 20 clinicians. Scaling was by 7 point Likert scale to enhanc
e responsiveness. English and French versions were developed. Conclusi
on. The JAQQ measures physical and psychosocial function and an array
of general symptoms. Preliminary data suggest it is valid and responsi
ve and thus might have potential in clinical trials.